Cogmed Training Effect in Hypertensive Patients With Cognitive Impairment

November 16, 2021 updated by: Regina Silva Paradela, University of Sao Paulo General Hospital

Cogmed Training Effect in Hypertensive Patients With Cognitive Impairment: a Randomized Clinical Trial

Systemic arterial hypertension is a disease with high prevalence in several countries, including Brazil. Many studies have correlated hypertension with accelerated loss of cognitive function, especially executive functions. There is some evidence that working memory (WM) is compromised in these populations. However, some computerized training has been developed to rehabilitate the WM, and among them the investigators highlight the Cogmed. Thus, the aim of this study is to evaluate the effects of Cogmed training in the performance of WM and attention of hypertensive patients, as well as the impact of training in the structure and brain function.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • São Paulo
      • Sao Paulo, São Paulo, Brazil, 05403-900
        • Regina Silva Paradela

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Individuals of both genders, of any ethnicity
  • Signing the consent form
  • Access to computer with internet at home
  • Inexperienced to computerized cognitive training
  • Hypertensive pre-diagnosed
  • Basic schooling of four years
  • Cognitive impairment

Exclusion Criteria:

  • Marked functional limitation
  • Cognitive limitation or serious communication
  • Severe neurological and psychiatric diseases
  • Stroke history, head trauma or substance abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adaptive training group
The intervention group will be composed of hypertensive participants with cognitive decline that will be submitted to the training program (Cogmed) for approximately 10 weeks. Across training, task difficulty was adjusted as a function of individual performance.
The Cogmed is computer software designed to train visuospatial and audio-verbal working memory, and other functions associated with working memory: attention, focus and impulsiveness. It has three versions adapted to different age groups: Cogmed for younger children, about 4-7 years, which are not yet so familiar with numbers and letters; Cogmed for children over 7 years and adolescents; and Cogmed for youth and adults over 18 years. In this study we will use the version for youth and adults over 18 years.
Active Comparator: Active control Group
In the control group, hypertensive patient will be submitted to a set of online games available on the internet and previously determined. In this way, the control group will receive the same motivation, as well as will be engaged in computerized activities, in the same way as the experimental group. The difference is that these varied games do not provide any type of intense and adaptive training, at the same time as they do not stimulate any specific cognitive function.
The Cogmed is computer software designed to train visuospatial and audio-verbal working memory, and other functions associated with working memory: attention, focus and impulsiveness. It has three versions adapted to different age groups: Cogmed for younger children, about 4-7 years, which are not yet so familiar with numbers and letters; Cogmed for children over 7 years and adolescents; and Cogmed for youth and adults over 18 years. In this study we will use the version for youth and adults over 18 years.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Working memory score
Time Frame: 10 weeks
Backward Digits Test / Letter-Number Sequencing (WAIS-III): total score (sum of right answers)
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brain function
Time Frame: 10 weeks
Functional magnetic resonance
10 weeks
Executive functions score
Time Frame: 10 weeks
Stroop test, Wisconsin Card Sorting Test, Frontal Assessment Battery and Controlled Oral Word Association Test
10 weeks
Verbal memory score
Time Frame: 10 weeks
Stories of Wechsler Memory Scale Revised - WMS R
10 weeks
Visual memory score
Time Frame: 10 weeks
Rey complex figure
10 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medication adherence score
Time Frame: 10 weeks
Short version of Morinsk Questionnaire
10 weeks
Quality of life score
Time Frame: 10 weeks
Whoqol
10 weeks
Perceived Stress score
Time Frame: 10 weeks
PSS14
10 weeks
Anxiety and Depression symptoms score
Time Frame: 10 weeks
BAI and BDI questionnaires
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Actual)

October 1, 2020

Study Completion (Actual)

December 1, 2020

Study Registration Dates

First Submitted

March 23, 2016

First Submitted That Met QC Criteria

April 13, 2016

First Posted (Estimate)

April 14, 2016

Study Record Updates

Last Update Posted (Actual)

November 17, 2021

Last Update Submitted That Met QC Criteria

November 16, 2021

Last Verified

November 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Cogmed

Subscribe